TEMPLATE

Leaders in Learning: Publications of Faculty & Staff

Medicine 2003-2004

ADAMS, P.C.

Adams, P.C., M.J. Arthur, T.D. Boyer, L.D. DeLeve, A.M. Di Bisceglie, M. Hall, T.R. Levin, D. Provenzale, and L. Seeff. 2004. Screening in liver disease: report of an AASLD clinical workshop. Hepatology 39 (5): 1204-12.

Adams, P.C., Y.P. Barbin, Z.A. Khan, and S. Chakrabarti. 2003. Expression of ferroportin in hemochromatosis liver. Blood Cells, Molecules & Diseases 31 (2): 256-61.

Power, T.E., and P.C. Adams. 2004. Hemochromatosis patients as voluntary blood donors. The Canadian Journal of Gastroenterology 18 (6): 393-6.

Yamashita, C., and P.C. Adams. 2003. Natural history of the C282Y homozygote for the hemochromatosis gene (HFE) with a normal serum ferritin level. Clinical Gastroenterology and Hepatology 1 (5): 388-91.

ARANY, E.

Joanette, E.A., B. Reusens, E. Arany, S. Thyssen, R.C. Remacle, and D.J. Hill. 2004. Low-protein diet during early life causes a reduction in the frequency of cells immunopositive for nestin and CD34 in both pancreatic ducts and islets in the rat. Endocrinology 145 (6): 3004-13.

ARNOLD, J.M.O.

Dzeka, T.N., R. Townley, and J.M. Arnold. 2003. Effects of enalaprilat on venoconstriction to norepinephrine: role of prostaglandins. Cardiovasc Res 59 (1): 250-256.

Gwadry-Sridhar, F., G.H. Guyatt, J.M. Arnold, D. Massel, J. Brown, L. Nadeau, and S. Lawrence. 2003. Instruments to measure acceptability of information and acquisition of knowledge in patients with heart failure. European Journal of Heart Failure 5 (6): 783-91.

BAILEY, D.G.

Bailey, D.G., and G.K. Dresser. 2004. Natural products and adverse drug interactions. CMAJ 170 (10): 1531-2.

Dresser, G.K., and D.G. Bailey. 2003. The effects of fruit juices on drug disposition: a new model for drug interactions. European Journal of Clinical Investigation 33 Suppl 2: 10-6.

BEHME, M.T.

Behme, M.T., J. Dupre, S.B. Harris, I.M. Hramiak, and J.L. Mahon. 2003. Insulin resistance in latent autoimmune diabetes of adulthood. Annals of the New York Academy of Sciences 1005: 374-7.

McKinney, J., H. Cao, M.T. Behme, J.L. Mahon, and R.A. Hegele. 2003. Maturity-onset diabetes of the young (MODY) mutation in type 2 diabetes and latent autoimmune diabetes of the adult. Diabetes Care 26 (12): 3358-9.

Summers, K.L., M.T. Behme, J.L. Mahon, and B. Singh. 2003. Characterization of dendritic cells in humans with type 1 diabetes. Annals of the New York Academy of Sciences 1005: 226-9.

BELL, D.A.

Hill, J.A., T.E. Ichim, K.P. Kusznieruk, M. Li, X. Huang, X. Yan, R. Zhong, E. Cairns, D.A. Bell, and W.P. Min. 2003. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. Journal of Immunology 171 (2): 691-6.

Hill, J.A., S. Southwood, A. Sette, A.M. Jevnikar, D.A. Bell, and E. Cairns. 2003. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. Journal of Immunology 171 (2): 538-41.

BLAKE, P.G.

Clark, W.F., A.X. Garg, P.G. Blake, G.A. Rock, A.P. Heidenheim, and D.L. Sackett. 2003. Effect of awareness of a randomized controlled trial on use of experimental therapy. JAMA 290 (10): 1351-5.

Suri, R., T.A. Depner, P.G. Blake, A.P. Heidenheim, and R.M. Lindsay. 2003. Adequacy of quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 42-8.

BOUGHNER, D.R.

Cimini, M., K.A. Rogers, and D.R. Boughner. 2003. Smoothelin-positive cells in human and porcine semilunar valves. Histochemistry and Cell Biology 120 (4): 307-17.

Jiang, H., G. Campbell, D. Boughner, W.K. Wan, and M. Quantz. 2004. Design and manufacture of a polyvinyl alcohol (PVA) cryogel tri-leaflet heart valve prosthesis. Medical Engineering & Physics 26 (4): 269-77.

Lacefield, J.C., J. Weaver, J.R. Spence, J. Dunmore-Buyze, and D.R. Boughner. 2004. Three-dimensional visualization and thickness estimation of aortic valve cusps using high-frequency ultrasound. Physiological Measurement 25 (1): 27-36.

White, J.A., P.W. Pflugfelder, D.R. Boughner, and W.J. Kostuk. 2003. Validation of a three-dimensional intravascular ultrasound imaging technique to assess atherosclerotic burden: potential for improved assessment of cardiac allograft coronary artery disease. The Canadian Journal of Cardiology 19 (10): 1147-53.

CAIRNS, E.

CHIN-YEE, I.H.

d'Almeida, M.S., M. White, C.M. Martin, W.J. Sibbald, and I.H. Chin-Yee. 2003. Effect of haemodilution with diaspirin cross-linked haemoglobin on the oxygen reserve in a rodent model of surgical blood loss. Transfusion Medicine 13 (5): 293-301.

Ho, J., W.J. Sibbald, and I.H. Chin-Yee. 2003. Effects of storage on efficacy of red cell transfusion: when is it not safe? Critical Care Medicine 31 (12 Suppl): S687-97.

CLARK, W.F.

Garg, A.X., R.S. Suri, N. Barrowman, F. Rehman, D. Matsell, M.P. Rosas-Arellano, M. Salvadori, R.B. Haynes, and W.F. Clark. 2003. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290 (10): 1360-70.

Kroeker, A., W.F. Clark, A.P. Heidenheim, L. Kuenzig, R. Leitch, M. Meyette, N. Muirhead, H. Ryan, R. Welch, S. White, and R.M. Lindsay. 2003. An operating cost comparison between conventional and home quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 49-55.

DRESSER, G.K.

Bailey, D.G., and G.K. Dresser. 2004. Natural products and adverse drug interactions. CMAJ 170 (10): 1531-2.

Dresser, G.K., and D.G. Bailey. 2003. The effects of fruit juices on drug disposition: a new model for drug interactions. European Journal of Clinical Investigation 33 Suppl 2: 10-6.

DREYER, J.F.

Bandiera, G., I.G. Stiell, G.A. Wells, C. Clement, V. De Maio, K.L. Vandemheen, G.H. Greenberg, H. Lesiuk, R. Brison, D. Cass, J. Dreyer, M.A. Eisenhauer, I. Macphail, R.D. McKnight, L. Morrison, M. Reardon, M. Schull, and J. Worthington. 2003. The Canadian C-spine rule performs better than unstructured physician judgment. Annals of Emergency Medicine 42 (3): 395-402.

Dickinson, G., I.G. Stiell, M. Schull, R. Brison, C.M. Clement, K.L. Vandemheen, D. Cass, D. McKnight, G. Greenberg, J.R. Worthington, M. Reardon, L. Morrison, M.A. Eisenhauer, J. Dreyer, and G.A. Wells. 2004. Retrospective application of the NEXUS low-risk criteria for cervical spine radiography in Canadian emergency departments. Annals of Emergency Medicine 43 (4): 507-14.

Stiell, I.G., C.M. Clement, R.D. McKnight, R. Brison, M.J. Schull, B.H. Rowe, J.R. Worthington, M.A. Eisenhauer, D. Cass, G. Greenberg, I. MacPhail, J. Dreyer, J.S. Lee, G. Bandiera, M. Reardon, B. Holroyd, H. Lesiuk, and G.A. Wells. 2003. The Canadian C-spine rule versus the NEXUS low-risk criteria in patients with trauma. The New England Journal of Medicine 349 (26): 2510-8.

Wells, P.S., D.R. Anderson, M. Rodger, M. Forgie, C. Kearon, J. Dreyer, G. Kovacs, M. Mitchell, B. Lewandowski, and M.J. Kovacs. 2003. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. The New England Journal of Medicine 349 (13): 1227-35.

DU, C.

Du, C., Q. Guan, Z. Yin, M. Masterson, R. Zhong, and A.M. Jevnikar. 2003. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury. Transplantation Proceedings 35 (7): 2481-2.

EISENHAUER, M.A.

FEAGAN, B.G.

Feagan, B.G. 2004. 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion. Clinical Gastroenterology and Hepatology 2 (5): 376-8.

Feagan, B.G. 2003. Maintenance therapy for inflammatory bowel disease. The American Journal of Gastroenterology 98 (12 Suppl): S6-S17.

Feagan, B.G., and A. Alfadhli. 2004. Methotrexate in inflammatory bowel disease. Gastroenterology Clinics of North America 33 (2): 407-20, xi.

Feagan, B.G., S. Yan, M. Bala, W. Bao, and G.R. Lichtenstein. 2003. The effects of infliximab maintenance therapy on health-related quality of life. The American Journal of Gastroenterology 98 (10): 2232-8.

Rutgeerts, P., B.G. Feagan, G.R. Lichtenstein, L.F. Mayer, S. Schreiber, J.F. Colombel, D. Rachmilewitz, D.C. Wolf, A. Olson, W. Bao, and S.B. Hanauer. 2004. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 126 (2): 402-13.

Sandborn, W.J., V.W. Fazio, B.G. Feagan, and S.B. Hanauer. 2003. AGA technical review on perianal Crohn's disease. Gastroenterology 125 (5): 1508-30.

Sandborn, W.J., and B.G. Feagan. 2003. Review article: Mild to moderate Crohn's disease--defining the basis for a new treatment algorithm. Alimentary Pharmacology & Therapeutics 18 (3): 263-77. Review Article.

Sandborn, W.J., D.H. Present, K.L. Isaacs, D.C. Wolf, E. Greenberg, S.B. Hanauer, B.G. Feagan, L. Mayer, T. Johnson, J. Galanko, C. Martin, and R.S. Sandler. 2003. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 125 (2): 380-8.

Sands, B.E., F.H. Anderson, C.N. Bernstein, W.Y. Chey, B.G. Feagan, R.N. Fedorak, M.A. Kamm, J.R. Korzenik, B.A. Lashner, J.E. Onken, D. Rachmilewitz, P. Rutgeerts, G. Wild, D.C. Wolf, P.A. Marsters, S.B. Travers, M.A. Blank, and S.J. van Deventer. 2004. Infliximab maintenance therapy for fistulizing Crohn's disease. The New England Journal of Medicine 350 (9): 876-85.

FELDMAN, R.D.

Hemmelgarn, B.R., K.B. Zarnke, N.R. Campbell, R.D. Feldman, D.W. McKay, F.A. McAlister, N. Khan, E.L. Schiffrin, M.G. Myers, P. Bolli, G. Honos, M. Lebel, M. Levine, and R. Padwal. 2004. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. The Canadian Journal of Cardiology 20 (1): 31-40.

Khan, N.A., F.A. McAlister, N.R. Campbell, R.D. Feldman, S. Rabkin, J. Mahon, R. Lewanczuk, K.B. Zarnke, B. Hemmelgarn, M. Lebel, M. Levine, and C. Herbert. 2004. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. The Canadian Journal of Cardiology 20 (1): 41-54.

Liu, S.L., S. Schmuck, J.Z. Chorazcyzewski, R. Gros, and R.D. Feldman. 2003. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation 108 (19): 2400-6.

FENG, Q.

Peng, T., X. Lu, M. Lei, G.W. Moe, and Q. Feng. 2003. Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia. Cardiovascular Research 59 (4): 893-900.

Rui, T., G. Cepinskas, Q. Feng, and P.R. Kvietys. 2003. Delayed preconditioning in cardiac myocytes with respect to development of a proinflammatory phenotype: role of SOD and NOS. Cardiovascular Research 59 (4): 901-11.

FREEMAN, D.J.

Ferguson, P.J., E. Kurowska, D.J. Freeman, A.F. Chambers, and D.J. Koropatnick. 2004. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. The Journal of Nutrition 134 (6): 1529-35.

GARG, A.

Garg, A. 2004. Review: ordering medications by computer can reduce medication errors. ACP Journal Club 140 (2): 52. Review.

Garg, A.X., A. Papaioannou, N. Ferko, G. Campbell, J.A. Clarke, and J.G. Ray. 2004. Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney International 65 (2): 649-53.

GEORGE, C.F.P.

George, C.F. 2003. Driving simulators in clinical practice. Sleep Medicine Reviews 7 (4): 311-20.

George, C.F., V. Kab, P. Kab, J.J. Villa, and A.M. Levy. 2003. Sleep and breathing in professional football players. Sleep Medicine 4 (4): 317-25.

GHENT, C.N.

Khakhar, A., E. Solano, D. Stell, M. Bloch, C. Dale, P. Burns, C. Ghent, D. Quan, V. McAlister, P. Marotta, and W.J. Wall. 2003. Survival after liver transplantation for hepatocellular carcinoma. Transplantation Proceedings 35 (7): 2438-41.

Sharpe, M.D., C. Ghent, D. Grant, G.L. Horbay, J. McDougal, and W. David Colby. 2003. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation 76 (6): 977-83.

Solano, E., A. Khakhar, M. Bloch, D. Quan, V. McAlister, C. Ghent, W. Wall, and P. Marotta. 2003. Liver transplantation for primary sclerosing cholangitis. Transplantation Proceedings 35 (7): 2431-4.

Thorburn, D., F.M. Sanai, and C.N. Ghent. 2003. Hepatocellular carcinoma presenting as right supraclavicular lymphadenopathy. The Canadian Journal of Gastroenterology 17 (10): 605-6.

GWADRY-SRIDHAR, F.

HARTH, M.

Harth, M., and W. Nielson. 2004. Comment on 'Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting.' by Hazemeijer and Rasker. Rheumatology (Oxford) 43 (2): 257; author reply 257-9. Comment.

Nielson, W.R., and M. Harth. 2004. Fibromyalgia: beyond the rhetoric. Journal of Rheumatology 31 (4): 631.

HEGELE, R.A.

Al-Shali, K.Z., and R.A. Hegele. 2004. Laminopathies and Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology

Cao, H., E. van der Veer, M.R. Ban, A.J. Hanley, B. Zinman, S.B. Harris, T.K. Young, J.G. Pickering, and R.A. Hegele. 2004. Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism 89 (2): 898-903.

Cao, H., C. Williams, M. Carter, and R.A. Hegele. 2004. CKN1 (MIM 216400): mutations in Cockayne syndrome type A and a new common polymorphism. Journal of Human Genetics 49 (1): 61-3.

Csoka, A.B., H. Cao, P.J. Sammak, D. Constantinescu, G.P. Schatten, and R.A. Hegele. 2004. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. Journal of Medical Genetics 41 (4): 304-8.

Dworatzek, P.D., R.A. Hegele, and T.M. Wolever. 2004. Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. The American Journal of Clinical Nutrition 79 (6): 1110-7.

Fenster, A., A. Landry, D.B. Downey, R.A. Hegele, and J.D. Spence. 2004. 3D ultrasound imaging of the carotid arteries. Current Drug Targets. Cardiovascular & Haematological Disorders 4 (2): 161-75.

Hegele, R.A. 2003. Drawing the line in progeria syndromes. Lancet 362 (9382): 416-7.

Hegele, R.A. 2004. Is regression of coronary atherosclerosis possible by infusing recombinant apolipoprotein A-I? CMAJ 170 (6): 954.

Hegele, R.A. 2003. Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome. Trends in Endocrinology and Metabolism 14 (8): 371-7.

Hegele, R.A. 2004. Phenomics, lipodystrophy, and the metabolic syndrome. Trends in Cardiovascular Medicine 14 (4): 133-7.

Joy, T., J. Wang, A. Hahn, and R.A. Hegele. 2003. APOA1 related amyloidosis: a case report and literature review. Clinical Biochemistry 36 (8): 641-5.

Lau, H.K., A. Segev, R.A. Hegele, J.D. Sparkes, J.M. Teitel, R.J. Chisholm, and B.H. Strauss. 2003. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis. Thrombosis and Haemostasis 90 (6): 1187-91.

Pollex, R.L., H.M. Khan, P.W. Connelly, T.K. Young, and R.A. Hegele. 2004. The metabolic syndrome in Inuit. Diabetes Care 27 (6): 1517-8.

Rowe, A.H., C.A. Argmann, J.Y. Edwards, C.G. Sawyez, O.H. Morand, R.A. Hegele, and M.W. Huff. 2003. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circulation Research 93 (8): 717-25.

Ruel, I.L., P. Couture, C. Gagne, Y. Deshaies, J. Simard, R.A. Hegele, and B. Lamarche. 2003. Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians. Journal of Lipid Research 44 (8): 1508-14.

Spence, J.D., and R.A. Hegele. 2004. Non-invasive assessment of atherosclerosis risk. Current Drug Targets. Cardiovascular & Haematological Disorders 4 (2): 125-8.

Spence, J.D., and R.A. Hegele. 2004. Noninvasive phenotypes of atherosclerosis: similar windows but different views. Stroke 35 (3): 649-53.

Wang, J., A.M. Huff, J.D. Spence, and R.A. Hegele. 2004. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Clinical Genetics 65 (6): 483-6.

HILL, D.J.

HODSMAN, A.B.

Hodsman, A.B., D.A. Hanley, M.P. Ettinger, M.A. Bolognese, J. Fox, A.J. Metcalfe, and R. Lindsay. 2003. Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. The Journal of Clinical Endocrinology and Metabolism 88 (11): 5212-20.

Hodsman, A.B., N. Platt, L. Stitt, M.J. Hodsman, S. Baker, L. Nicholson, and B. Nicholson. 2004. Evaluation of an osteoporosis self-referral program to enhance management outcomes. Journal of Clinical Densitometry 7 (1): 77-84.

Olszynski, W.P., K. Shawn Davison, J.D. Adachi, J.P. Brown, S.R. Cummings, D.A. Hanley, S.P. Harris, A.B. Hodsman, D. Kendler, M.R. McClung, P.D. Miller, and C.K. Yuen. 2004. Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clinical Therapeutics 26 (1): 15-28.

HOLLOMBY, D.J.

Muirhead, N., A. House, D.J. Hollomby, and A.M. Jevnikar. 2003. A comparison between cyclosporine and tacrolimus-based immunosuppression for renal allografts: renal function and blood pressure after 5 years. Transplantation Proceedings 35 (7): 2391-4.

Muirhead, N., A. House, D.J. Hollomby, and A.M. Jevnikar. 2003. Effect of valsartan on urinary protein excretion and renal function in patients with chronic renal allograft nephropathy. Transplantation Proceedings 35 (7): 2412-4.

HOUSE, A.

Moist, L.M., D.N. Churchill, A.A. House, S.F. Millward, J.E. Elliott, S.W. Kribs, W.J. DeYoung, L. Blythe, L.W. Stitt, and R.M. Lindsay. 2003. Regular Monitoring of Access Flow Compared with Monitoring of Venous Pressure Fails to Improve Graft Survival. Journal of the American Society of Nephrology 14 (10): 2645-2653.

HOWSON-JAN, K.

Bredeson, C., C. Leger, S. Couban, D. Simpson, L. Huebsch, I. Walker, T. Shore, K. Howson-Jan, T. Panzarella, H. Messner, M. Barnett, and J. Lipton. 2004. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biology of Blood and Marrow Transplantation 10 (6): 405-14.

HRAMIAK, I.M.

Behme, M.T., J. Dupre, S.B. Harris, I.M. Hramiak, and J.L. Mahon. 2003. Insulin resistance in latent autoimmune diabetes of adulthood. Annals of the New York Academy of Sciences 1005: 374-7.

HUFF, M. W.

Borradaile, N.M., L.E. de Dreu, and M.W. Huff. 2003. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 52 (10): 2554-61.

HUMEN, D.

Beanlands, R., G. Nichol, T.D. Ruddy, R.A. deKemp, P. Hendry, D. Humen, N. Racine, H. Ross, F. Benard, G. Coates, R.M. Iwanochko, E. Fallen, and G. Wells. 2003. Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods. Controlled Clinical Trials 24 (6): 776-94.

HUSSAIN, Z.

Elsayed, S., O. Hammerberg, V. Massey, and Z. Hussain. 2003. Streptococcus equi subspecies equi (Lancefield group C) meningitis in a child. Clinical Microbiology and Infection 9 (8): 869-72.

JEVNIKAR, A.M.

Luke, P.P., J.P. Deng, C.A. O'Brien, M. Everest, A.V. Hall, S. Chakrabarti, P.J. O'Connell, R. Zhong, and A.M. Jevnikar. 2003. Alteration in CD45RBhi/CD45RBlo T-cell ratio following CD45RB monoclonal-antibody therapy occurs by selective deletion of CD45RBhi effector cells. Transplantation 76 (2): 400-9.

Luke, P.P., D.B. Herz, M.F. Bellinger, P. Chakrabarti, C.A. Vivas, V.P. Scantlebury, T.R. Hakala, A.M. Jevnikar, A. Jain, R. Shapiro, and M.L. Jordan. 2003. Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation 76 (11): 1578-82.

Ma, S., Y. Huang, Z. Yin, R. Menassa, J.E. Brandle, and A.M. Jevnikar. 2004. Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. Proceedings of the National Academy of Sciences of the U.S.A. 101 (15): 5680-5.

Zhou, D., C. O'Brien, J. Shum, B. Garcia, W. Min, A.M. Jevnikar, P. Dutartre, and R. Zhong. 2003. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model. Transplantation 76 (4): 644-50.

KLEIN, G.J.

Assar, M.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2003. Optimal duration of monitoring in patients with unexplained syncope. The American Journal of Cardiology 92 (10): 1231-3.

Chauhan, V.S., A.D. Krahn, G.J. Klein, A.C. Skanes, and R. Yee. 2004. Utility of a simplified lidocaine and potassium infusion in diagnosing long QT syndrome among patients with borderline QTc interval prolongation. Annals of Noninvasive Electrocardiology 9 (1): 12-8.

Gula, L.J., A.D. Krahn, D. Massel, A. Skanes, R. Yee, and G.J. Klein. 2004. External loop recorders: determinants of diagnostic yield in patients with syncope. The American Heart Journal 147 (4): 644-8.

Gula, L.J., A.D. Krahn, A.C. Skanes, R. Yee, and G.J. Klein. 2004. Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart 90 (3): 347-52.

Gula, L.J., A. Skanes, A.D. Krahn, and G.J. Klein. 2004. Novel approach to diagnosis of a wide-complex tachycardia. Journal of Cardiovascular Electrophysiology 15 (4): 466-9.

Huang, M., A.D. Krahn, R. Yee, G.J. Klein, and A.C. Skanes. 2004. Optimal pacing for symptomatic AV block: a comparison of VDD and DDD pacing. Pacing and Clinical Electrophysiology 27 (1): 19-23.

Huang, M., A.D. Krahn, R. Yee, G.J. Klein, and A.C. Skanes. 2003. Optimal pacing for symptomatic AV block: a comparison of VDD and DDD pacing. Pacing and Clinical Electrophysiology 26 (12): 2230-4.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2004. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing and Clinical Electrophysiology 27 (5): 657-64.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2003. Use of the implantable loop recorder in evaluation of patients with unexplained syncope. Journal of Cardiovascular Electrophysiology 14 (9 Suppl): S70-3.

Krahn, A.D., G.J. Klein, R. Yee, J.S. Hoch, and A.C. Skanes. 2003. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. Journal of the American College of Cardiology 42 (3): 495-501.

Lelorier, P., K.H. Humphries, A. Krahn, S.J. Connolly, M. Talajic, M. Green, R. Sheldon, P. Dorian, D. Newman, C.R. Kerr, R. Yee, and G.J. Klein. 2004. Prognostic differences between atrial fibrillation and atrial flutter. The American Journal of Cardiology 93 (5): 647-9.

LeLorier, P., G.J. Klein, A. Krahn, R. Yee, A. Skanes, and J.K. Shoemaker. 2003. Combined head-up tilt and lower body negative pressure as an experimental model of orthostatic syncope. Journal of Cardiovascular Electrophysiology 14 (9): 920-4.

Sivakumaran, S., A.D. Krahn, G.J. Klein, J. Finan, R. Yee, S. Renner, and A.C. Skanes. 2003. A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. The American Journal of Medicine 115 (1): 1-5.

Skanes, A.C., G.J. Klein, G. Guiraudon, A.H. Menkis, D.L. Jones, A.D. Krahn, and R. Yee. 2003. Hybrid approach for minimally-invasive operative therapy of arrhythmias. Journal of Interventional Cardiac Electrophysiology 9 (2): 289-94.

Todd, D.M., A.C. Skanes, G. Guiraudon, C. Guiraudon, A.D. Krahn, R. Yee, and G.J. Klein. 2003. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 108 (25): 3108-14.

Trim, G.M., A.D. Krahn, G.J. Klein, A.C. Skanes, and R. Yee. 2003. Pacing for vasovagal syncope after the second Vasovagal Pacemaker Study (VPS II): a matter of judgement. Cardiac Electrophysiology Review 7 (4): 416-20.

Walker, B.D., A.D. Krahn, G.J. Klein, A.C. Skanes, and R. Yee. 2003. Drug induced QT prolongation: lessons from congenital and acquired long QT syndromes. Current Drug Targets. Cardiovascular & Haematological Disorders 3 (4): 327-35.

Yee, R., G.J. Klein, A.C. Krahn, and A.C. Skanes. 2004. Selective site pacing: tools and training. Pacing and Clinical Electrophysiology 27 (6 Pt 2): 894-6.

KORTAS, C.

Al-Hejaili, F., C. Kortas, R. Leitch, A.P. Heidenheim, L. Clement, G. Nesrallah, and R.M. Lindsay. 2003. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. Journal of the American Society of Nephrology 14 (9): 2322-8.

Heidenheim, A.P., R. Leitch, C. Kortas, and R.M. Lindsay. 2003. Patient monitoring in the London Daily/Nocturnal Hemodialysis Study. American Journal of Kidney Diseases 42 (1 Suppl): 61-5.

Lindsay, R.M., F. Alhejaili, G. Nesrallah, R. Leitch, L. Clement, A.P. Heidenheim, and C. Kortas. 2003. Calcium and phosphate balance with quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 24-9.

Lindsay, R.M., R. Leitch, A.P. Heidenheim, and C. Kortas. 2003. The London Daily/Nocturnal Hemodialysis Study--study design, morbidity, and mortality results. American Journal of Kidney Diseases 42 (1 Suppl): 5-12.

Mehrabian, S., D. Morgan, C. Schlaeper, C. Kortas, and R.M. Lindsay. 2003. Equipment and water treatment considerations for the provision of quotidian home hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 66-70.

Nesrallah, G., R. Suri, L. Moist, C. Kortas, and R.M. Lindsay. 2003. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 13-7.

KOSTUK, W.J.

KOVACS, M.J.

Crowther, M.A., J.S. Ginsberg, J. Julian, J. Denburg, J. Hirsh, J. Douketis, C. Laskin, P. Fortin, D. Anderson, C. Kearon, A. Clarke, W. Geerts, M. Forgie, D. Green, L. Costantini, W. Yacura, S. Wilson, M. Gent, and M.J. Kovacs. 2003. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. The New England Journal of Medicine 349 (12): 1133-8.

Kearon, C., J.S. Ginsberg, D.R. Anderson, M.J. Kovacs, P. Wells, J.A. Julian, B. Mackinnon, C. Demers, J. Douketis, A.G. Turpie, P. Van Nguyen, D. Green, J. Kassis, S.R. Kahn, S. Solymoss, L. Desjardins, W. Geerts, M. Johnston, J.I. Weitz, J. Hirsh, and M. Gent. 2004. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis 2 (5): 743-9.

Kearon, C., J.S. Ginsberg, M.J. Kovacs, D.R. Anderson, P. Wells, J.A. Julian, B. MacKinnon, J.I. Weitz, M.A. Crowther, S. Dolan, A.G. Turpie, W. Geerts, S. Solymoss, P. van Nguyen, C. Demers, S.R. Kahn, J. Kassis, M. Rodger, J. Hambleton, and M. Gent. 2003. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. The New England Journal of Medicine 349 (7): 631-9.

Kovacs, M.J. 2004. D-dimer levels < 250 ng/mL after oral anticoagulation predicted a low risk for recurrent venous thromboembolism. ACP Journal Club 140 (2): 50.

Lee, A.Y., M.N. Levine, R.I. Baker, C. Bowden, A.K. Kakkar, M. Prins, F.R. Rickles, J.A. Julian, S. Haley, M.J. Kovacs, and M. Gent. 2003. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of Medicine 349 (2): 146-53.

Payne, S., K. MacKinnon, M. Keeney, B. Morrow, and M.J. Kovacs. 2003. Effect of 3.2 vs. 3.8% sodium citrate concentration on anti-Xa levels for patients on therapeutic low molecular weight heparin. Clinical and Laboratory Haematology 25 (5): 317-9.

Wilson, S.J., P.S. Wells, M.J. Kovacs, G.M. Lewis, J. Martin, E. Burton, and D.R. Anderson. 2003. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 169 (4): 293-8.

KRAHN, A.D.

Assar, M.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2003. Optimal duration of monitoring in patients with unexplained syncope. The American Journal of Cardiology 92 (10): 1231-3.

Gula, L.J., A.D. Krahn, A.C. Skanes, R. Yee, and G.J. Klein. 2004. Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart 90 (3): 347-52.

Gula, L.J., A. Skanes, A.D. Krahn, and G.J. Klein. 2004. Novel approach to diagnosis of a wide-complex tachycardia. Journal of Cardiovascular Electrophysiology 15 (4): 466-9.

Krahn, A.D., S.J. Connolly, R.S. Roberts, and M. Gent. 2004. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. The American Heart Journal 147 (5): 837-40.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2004. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing and Clinical Electrophysiology 27 (5): 657-64.

Petrellis, B., A.C. Skanes, A.D. Krahn, and R. Yee. 2004. A wide QRS tachycardia: what is the diagnosis? Journal of Cardiovascular Electrophysiology 15 (4): 501-3.

Yee, R., G.J. Klein, A.C. Krahn, and A.C. Skanes. 2004. Selective site pacing: tools and training. Pacing and Clinical Electrophysiology 27 (6 Pt 2): 894-6.

LEWIS, J.F.

Bailey, T.C., K.A. Da Silva, J.F. Lewis, K. Rodriguez-Capote, F. Possmayer, and R.A. Veldhuizen. 2004. Physiological and inflammatory response to instillation of an oxidized surfactant in a rat model of surfactant deficiency. Journal of Applied Physiology 96 (5): 1674-80.

Kerr, C.L., L.A. McCaig, R.A. Veldhuizen, and J.F. Lewis. 2003. High-frequency oscillation and exogenous surfactant administration in lung-injured adult sheep. Critical Care Medicine 31 (10): 2520-6.

Lewis, J.F. 2004. Surfactant - where are we in 2003? Canadian Respiratory Journal 11 (3): 204-6.

LINDSAY, R.M.

Heidenheim, A.P., R. Leitch, C. Kortas, and R.M. Lindsay. 2003. Patient monitoring in the London Daily/Nocturnal Hemodialysis Study. American Journal of Kidney Diseases 42 (1 Suppl): 61-5.

Heidenheim, A.P., N. Muirhead, L. Moist, and R.M. Lindsay. 2003. Patient quality of life on quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 36-41.

Leitch, R., M. Ouwendyk, E. Ferguson, L. Clement, K. Peters, A.P. Heidenheim, and R.M. Lindsay. 2003. Nursing issues related to patient selection, vascular access, and education in quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 56-60.

Lindsay, R.M. 2004. The London, Ontario, Daily/Nocturnal Hemodialysis Study. Seminars in Dialysis 17 (2): 85-91.

Lindsay, R.M., and C.R. Blagg. 2003. The London daily/nocturnal hemodialysis study: a review. Nephrology News & Issues 17 (12): 55-8.

Nesrallah, G.E., L.M. Moist, C. Awaraji, and R.M. Lindsay. 2004. An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls. Seminars in Dialysis 17 (2): 131-5.

Rao, M., N. Muirhead, S. Klarenbach, L. Moist, and R.M. Lindsay. 2003. Management of anemia with quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 18-23.

Spanner, E., R. Suri, A.P. Heidenheim, and R.M. Lindsay. 2003. The impact of quotidian hemodialysis on nutrition. American Journal of Kidney Diseases 42 (1 Suppl): 30-5.

Suri, R., T.A. Depner, P.G. Blake, A.P. Heidenheim, and R.M. Lindsay. 2003. Adequacy of quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 42-8.

LUCAS, A.R.

Bedard, E.L., P. Kim, J. Jiang, N. Parry, L. Liu, H. Wang, B. Garcia, X. Li, G. McFadden, A. Lucas, and R. Zhong. 2003. Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 76 (1): 249-52.

Liu, L., E. Dai, L. Miller, B. Seet, A. Lalani, C. Macauley, X. Li, H.W. Virgin, C. Bunce, P. Turner, R. Moyer, G. McFadden, and A. Lucas. 2004. Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation 77 (11): 1652-60.

MAHON, J.L.

Behme, M.T., J. Dupre, S.B. Harris, I.M. Hramiak, and J.L. Mahon. 2003. Insulin resistance in latent autoimmune diabetes of adulthood. Annals of the New York Academy of Sciences 1005: 374-7.

Blanchard, C., D. Feeny, J.L. Mahon, R. Bourne, C. Rorabeck, L. Stitt, and S. Webster-Bogaert. 2003. Is the Health Utilities Index responsive in total hip arthroplasty patients? Journal of Clinical Epidemiology 56 (11): 1046-54.

Blanchard, C., D. Feeny, J.L. Mahon, R. Bourne, C. Rorabeck, L. Stitt, and S. Webster-Bogaert. 2004. Is the Health Utilities Index valid in total hip arthroplasty patients? Quality of Life Research 13 (2): 339-48.

Feeny, D., C.M. Blanchard, J.L. Mahon, R. Bourne, C. Rorabeck, L. Stitt, and S. Webster-Bogaert. 2004. The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty. Quality of Life Research 13 (1): 15-22.

Summers, K.L., M.T. Behme, J.L. Mahon, and B. Singh. 2003. Characterization of dendritic cells in humans with type 1 diabetes. Annals of the New York Academy of Sciences 1005: 226-9.

MAROTTA, P.

Krowka, M.J., M.S. Mandell, M.A. Ramsay, S.M. Kawut, M.B. Fallon, C. Manzarbeitia, M. Pardo Jr, P. Marotta, S. Uemoto, M.P. Stoffel, and J.T. Benson. 2004. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transplantation 10 (2): 174-82.

Levy, G., F. Villamil, D. Samuel, F. Sanjuan, G.L. Grazi, Y. Wu, P. Marotta, O. Boillot, F. Muehlbacher, and G. Klintmalm. 2004. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation 77 (11): 1632-8.

MARTIN, C.M.

Martin, C.M., G.S. Doig, D.K. Heyland, T. Morrison, and W.J. Sibbald. 2004. Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ 170 (2): 197-204.

MASSEL, D.R.

Gula, L.J., A. Dick, and D. Massel. 2003. Diagnosing acute myocardial infarction in the setting of left bundle branch block: prevalence and observer variability from a large community study. Coronary Artery Disease 14 (5): 387-93.

Massel, D. 2004. Anticoagulation. CMAJ 170 (4): 447; author reply 451.

Massel, D. 2004. Composite confusion. Journal of the American College of Cardiology 43 (10): 1926-7; author reply 1927.

Massel, D. 2004. Evidence for use of coronary stents. Annals of Internal Medicine 140 (2): W4.

Massel, D. 2003. The number needed to harm: is it too optimistic? The Canadian Journal of Cardiology 19 (13): 1490-2.

Massel, D., and G. Marchiori. 2004. Precision and accuracy of the bedside examination in detecting an ejection fraction of less than 40% following acute myocardial infarction. The Canadian Journal of Cardiology 20 (4): 411-6.

Prabhakar, M., and D. Massel. 2003. Adjunctive treatment with eplerenone reduced morbidity and mortality in acute myocardial infarction. ACP Journal Club 139 (2): 32.

MCCORMACK, D.G.

Yaghi, A., J.R. Bend, C.D. Webb, D.C. Zeldin, S. Weicker, S. Mehta, and D.G. McCormack. 2004. Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia. American Journal of Physiology. Lung Cellular and Molecular Physiology 286 (6): L1260-7.

Yaghi, A., J.A. Bradbury, D.C. Zeldin, S. Mehta, J.R. Bend, and D.G. McCormack. 2003. Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia. American Journal of Physiology. Lung Cellular and Molecular Physiology 285 (5): L1099-105.

MCDONALD, C.L.

Scholten, D.J., A.K. Malla, R.M. Norman, T.S. McLean, E.M. McIntosh, C.L. McDonald, M. Eliasziw, and K.N. Speechley. 2003. Removing barriers to treatment of first-episode psychotic disorders. Canadian Journal of Psychiatry 48 (8): 561-5.

MEHTA, S.

Mehta, S. 2003. Drug therapy for pulmonary arterial hypertension: what's on the menu today? Chest 124 (6): 2045-9.

MOIST, L.

Heidenheim, A.P., N. Muirhead, L. Moist, and R.M. Lindsay. 2003. Patient quality of life on quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 36-41.

Rao, M., N. Muirhead, S. Klarenbach, L. Moist, and R.M. Lindsay. 2003. Management of anemia with quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 18-23.

MUIRHEAD, N.

Heidenheim, A.P., N. Muirhead, L. Moist, and R.M. Lindsay. 2003. Patient quality of life on quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 36-41.

Rao, M., N. Muirhead, S. Klarenbach, L. Moist, and R.M. Lindsay. 2003. Management of anemia with quotidian hemodialysis. American Journal of Kidney Diseases 42 (1 Suppl): 18-23.

NIELSON, W.R.

Jensen, M.P., W.R. Nielson, J.A. Turner, J.M. Romano, and M.L. Hill. 2003. Readiness to self-manage pain is associated with coping and with psychological and physical functioning among patients with chronic pain. Pain 104 (3): 529-37.

Nielson, W.R., and M. Harth. 2004. Fibromyalgia: beyond the rhetoric. Journal of Rheumatology 31 (4): 631.

PFLUGFELDER, P.W.

PICKERING, J.G.

Fera, E., C. O'Neil, W. Lee, S. Li, and J.G. Pickering. 2004. FGF-2 and remodeled type I collagen control membrane protrusion in human vascular smooth muscle cells: biphasic activation of Rac1. The Journal of Biological Chemistry

Li, S., C. Van Den Diepstraten, S.J. D'Souza, B.M. Chan, and J.G. Pickering. 2003. Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization. The American Journal of Pathology 163 (3): 1045-56.

Van Den Diepstraten, C., K. Papay, Z. Bolender, A. Brown, and J.G. Pickering. 2003. Cloning of a novel prolyl 4-hydroxylase subunit expressed in the fibrous cap of human atherosclerotic plaque. Circulation 108 (5): 508-11.

POPE, J.E.

Hong, P., J.E. Pope, J.M. Ouimet, E. Rullan, and J.R. Seibold. 2004. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. The Journal of Rheumatology 31 (3): 508-13.

Pope, J.E. 2004. Hypertension, NSAID, and lessons learned. The Journal of Rheumatology 31 (6): 1035-7.

Pope, J.E., A. Krizova, J.M. Ouimet, J.L. Goodwin, and M. Lankin. 2004. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory nusculoskeletal disorders. The Journal of Rheumatology 31 (2): 274-9.

Pope, J.E., K. McCrea, A. Stevens, and J.M. Ouimet. 2004. Treatment of osteoarthritis of the hip and knee: a comparison of NSAID use in patients for whom surgery was and was not recommended. Clinical and Experimental Rheumatology 22 (2): 171-6.

Pope, J.E., M. Prashker, and J. Anderson. 2004. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis. The Journal of Rheumatology 31 (1): 140-9.

Sultan, N., J.E. Pope, and P.J. Clements. 2004. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma. Rheumatology (Oxford) 43 (4): 472-8.

REHMAN, F.

RODGER, N.W.

Hernandez, C.A., M.R. Hume, and N.W. Rodger. 2003. Six-month evaluation of a diabetes self-awareness intervention. Outcomes Management 7 (4): 148-56; quiz 157-8.

Tudor-Locke, C., R.C. Bell, A.M. Myers, S.B. Harris, N.A. Ecclestone, N. Lauzon, and N.W. Rodger. 2004. Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes. International Journal of Obesity and Related Metabolic Disorders 28 (1): 113-9.

SKANES, A.C.

Assar, M.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2003. Optimal duration of monitoring in patients with unexplained syncope. The American Journal of Cardiology 92 (10): 1231-3.

Gula, L.J., A.D. Krahn, A.C. Skanes, R. Yee, and G.J. Klein. 2004. Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart 90 (3): 347-52.

Gula, L.J., A. Skanes, A.D. Krahn, and G.J. Klein. 2004. Novel approach to diagnosis of a wide-complex tachycardia. Journal of Cardiovascular Electrophysiology 15 (4): 466-9.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2004. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing and Clinical Electrophysiology 27 (5): 657-64.

Petrellis, B., A.C. Skanes, A.D. Krahn, and R. Yee. 2004. A wide QRS tachycardia: what is the diagnosis? Journal of Cardiovascular Electrophysiology 15 (4): 501-3.

Yee, R., G.J. Klein, A.C. Krahn, and A.C. Skanes. 2004. Selective site pacing: tools and training. Pacing and Clinical Electrophysiology 27 (6 Pt 2): 894-6.

THOMPSON, G.B.F.

Plint, A.C., D.W. Johnson, N. Wiebe, B. Bulloch, M. Pusic, G. Joubert, P. Pianosi, T. Turner, G. Thompson, and T.P. Klassen. 2004. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Academic Emergency Medicine 11 (4): 353-60.

VELDHUIZEN, R.

Laffey, J.G., D. Engelberts, M. Duggan, R. Veldhuizen, J.F. Lewis, and B.P. Kavanagh. 2003. Carbon dioxide attenuates pulmonary impairment resulting from hyperventilation. Critical Care Medicine 31 (11): 2634-40.

Martin, E.L., B.Z. Moyer, M.C. Pape, B. Starcher, K.J. Leco, and R.A. Veldhuizen. 2003. Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis. American Journal of Physiology. Lung Cellular and Molecular Physiology 285 (6): L1222-32.

Zenri, H., K. Rodriquez-Capote, L. McCaig, L.J. Yao, A. Brackenbury, F. Possmayer, R. Veldhuizen, and J. Lewis. 2004. Hyperoxia exposure impairs surfactant function and metabolism. Critical Care Medicine 32 (5): 1155-60.

WISENBERG, G.

Lekx, K.S., F.S. Prato, J. Sykes, and G. Wisenberg. 2004. The partition coefficient of Gd-DTPA reflects maintained tissue viability in a canine model of chronic significant coronary stenosis. Journal of Cardiovascular Magnetic Resonance 6 (1): 33-42.

YEE, R.

Assar, M.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2003. Optimal duration of monitoring in patients with unexplained syncope. The American Journal of Cardiology 92 (10): 1231-3.

Gula, L.J., A.D. Krahn, A.C. Skanes, R. Yee, and G.J. Klein. 2004. Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart 90 (3): 347-52.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2004. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing and Clinical Electrophysiology 27 (5): 657-64.

Petrellis, B., A.C. Skanes, A.D. Krahn, and R. Yee. 2004. A wide QRS tachycardia: what is the diagnosis? Journal of Cardiovascular Electrophysiology 15 (4): 501-3.

Yee, R., G.J. Klein, A.C. Krahn, and A.C. Skanes. 2004. Selective site pacing: tools and training. Pacing and Clinical Electrophysiology 27 (6 Pt 2): 894-6.

ZARNKE, K.B.